Cardiol Therapeutics Inc. Adjustments For Decrease Increase In Prepaid Expenses
Cardiol Therapeutics Inc. (CRDL) reported Adjustments For Decrease Increase In Prepaid Expenses of -CAD 1.13 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Operating Expenses
ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses · last filed 2026-03-31
| Period end | Adjustments For Decrease Increase In Prepaid Expenses 12 month |
|---|---|
| 2025-12-31 | -1.13M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 214.93K CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | 546.47K CAD 40-F · filed 2025-03-31 |
| 2022-12-31 | 1.35M CAD 20-F · filed 2024-04-01 |
| 2021-12-31 | -2.15M CAD 20-F · filed 2024-04-01 |
| 2020-12-31 | -64.14K CAD 20-F · filed 2023-03-29 |